2013
DOI: 10.1016/j.bbagen.2013.05.018
|View full text |Cite
|
Sign up to set email alerts
|

Collagen based magnetic nanobiocomposite as MRI contrast agent and for targeted delivery in cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(11 citation statements)
references
References 30 publications
0
10
1
Order By: Relevance
“…the resistance to change for the composite developed in this study was greater than 19% as against 3% reported for poly (lactide-ε-caprolactone)/collagen/nano-hydroxyapatite composite80. Compared to previous reports81 the nanoparticles developed in this study had a lower cytotoxicity due to the presence of the polysaccharide corona, leading to the possibility of offering higher doses of collagen-nanoparticle composites for imaging purposes. The polysaccharide corona also provides for a higher r 1 at low r 2 /r 1 , leading to its function as a better T 1 contrast agent.…”
Section: Resultscontrasting
confidence: 49%
“…the resistance to change for the composite developed in this study was greater than 19% as against 3% reported for poly (lactide-ε-caprolactone)/collagen/nano-hydroxyapatite composite80. Compared to previous reports81 the nanoparticles developed in this study had a lower cytotoxicity due to the presence of the polysaccharide corona, leading to the possibility of offering higher doses of collagen-nanoparticle composites for imaging purposes. The polysaccharide corona also provides for a higher r 1 at low r 2 /r 1 , leading to its function as a better T 1 contrast agent.…”
Section: Resultscontrasting
confidence: 49%
“…Modifications of magnetic NPs make them interesting options for cancer therapeutic systems. Collagen-based magnetic nanobiocomposites have been established as an MRI contrast agent and as a carrier for delivering cancer drugs [128]. Since iron oxide NPs use folate receptors to enter cells, over-expression of this receptor on the surface of cancer cells, as previously demonstrated [129], may be a useful point for an anticancer drug delivery approach using these NPs [130].…”
Section: Iron Oxide Nanoparticlesmentioning
confidence: 99%
“…Naskar, Ghosh, and Moulik (2012) have also recently reported about the effect of various additives on aqueous normal and reverse PEO/PPO micelles. Therefore, even though there are a variety of structures including microspheres (Mathiowitz et al, 1997;Matsumoto, Matsukawa, Suzuki, Yoshino, & Kobayashi, 1997), dendrimers (Gillies & Frechet, 2005), liposomes (Allen, 1998;Ramachandran, Quist, Kumar, & Lal, 2006;Samad, Sultana, & Aqil, 2007;Yatvin, Weinstein, Dennis, & Blumenthal, 1978), carbon nanohorns (Ajima et al, 2005(Ajima et al, , 2008Murakami et al, 2004), carbon nanotubes (Guven et al, 2012), and nanoparticles; gold (Mohanty, Thennarasu, & Mandal, 2014), silver , Fe 3 O 4 (Cheng, Peng, Xu, & Sun, 2009;Mandal, Sekar, Kanagavel, et al, 2013), pH-responsive compounds (Oishi, Hayashi, Iijima, & Nagasaki, 2007;Xu et al, 2006), and silica (Barbe et al, 2004;Slowing, Trewyn, Giri, & Lin, 2007); that can be used as drug delivery agents, polymeric micelles' high drug-loading ability and toxicity shield effect (Cammas & Kataoka, 1996;Kreuter et al, 1994;Kwon & Kataoka, 1995;Kwon & Okano, 1996;Scholes et al, 1997) suggests they are sufficient drug delivery platforms to compliment other used drug delivery materials.…”
Section: Introductionmentioning
confidence: 99%